I realise that Zanubrutinib is a newish BTKi to the market, especially in the UK but if anyone (in or outside the UK) has any experience of this drug, good or bad, I would be grateful if you could share it to assist CLL Support in their submission for the appraisal.
NICE do like to hear of real patients' experience of any drug that they are evaluating. You can either reply to this post or send me a PM over the next few day if you can (the timeline is a short one).
Many thanks in advance
Jackie